Search

Current filters: Treatment, Reproductive and maternal health, Women

Decreasing the risk of neural tube defects with dolutegravir

From TreatmentUpdate 233
2019, CATIE
Research summary - Webpage

FDA warns that Prezcobix should not be used by HIV-positive pregnant women

From TreatmentUpdate 228
2018, CATIE
Research summary - Webpage

Agencies issue caution about use of dolutegravir by pregnant HIV-positive women

2018, CATIE
Research summary - Webpage

Quebec study is reassuring about the safety of HIV treatment during pregnancy

2017, CATIE
Research summary - Webpage

Canadian researchers review the use of raltegravir in pregnancy

2016, CATIE
Research summary - Webpage

U.S. study reviews use and impact of integrase inhibitors in pregnancy

2016, CATIE
Research summary - Webpage

A successful pregnancy and birth outcome with dolutegravir-based ART

From TreatmentUpdate 212
2016, CATIE
Research summary - Webpage

Dolutegravir—Interaction with atazanavir during pregnancy

From TreatmentUpdate 212
2016, CATIE
Research summary - Webpage

Premature births, protease inhibitors and progesterone

From TreatmentUpdate 206
2015, CATIE
Research summary - Webpage

8. Menstrual Changes

From A Practical Guide to HIV Drug Side Effects
2013, CATIE
Client resources - Webpage